A carregar...
A signature enrichment design with Bayesian adaptive randomization
Clinical trials in the era of precision cancer medicine aim to identify and validate biomarker signatures which can guide the assignment of individually optimal treatments to patients. In this article, we propose a group sequential randomized phase II design, which updates the biomarker signature as...
Na minha lista:
| Publicado no: | J Appl Stat |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8132854/ https://ncbi.nlm.nih.gov/pubmed/34024982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/02664763.2020.1757048 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|